Recombinant human Adiponectin/Acrp30 protein from NKMAX Co. Ltd.
Search, find, compare suppliers for Recombinant human Adiponectin/Acrp30 protein products.
| Edit | |
|---|---|
| Product Name | Recombinant human Adiponectin/Acrp30 protein |
| Description | Domain: 15-244aa. Human Adiponectin, also referred to as AdipoQ, Acrp30, apm-1 or GBP28, is a secreted protein expressed exclusively in differentiated adipocyte (adipokine). Adiponectin contains a modular structure comprising an N-terminal collagenous domain followed by a C-terminal globular domain. Adiponectin plays a role in various physiological processes such as energy homeostasis and obesity. Plasma levels of adiponectin are reduced in obese humans, and decreased levels are associated with insulin resistance and hyperinsulinemia. MW: 25.1 kDa (231aa). Purity > 90% by SDS-PAGE. |
| Size | 20ug, 100ug, 500ug |
| Concentration | 0.5mg/ml (determined by Bradford assay) |
| Applications | SDS-PAGE |
| Other Names | AdipoQ, ACDC, ACRP30, APM1, GBP28, Adiponectin, Adipocyte, C1q and collagen domain-containing protein, 30 kDa adipocyte complement-related protein, Adipocyte complement-related 30 kDa protein, ACRP30, Adipose most abundant gene transcript 1 protein, apM-1, Gelati, 30 kDa adipocyte complement related protein, ACRP 30, Adipocyte C1q and collagen domain containing protein, Adipocyte complement related 30 kDa protein, Adipocyte complement related protein of 30 kDa, Adipose most abundant gene transcript 1, APM 1, GBP 28, Gelatin binding protein, |
| Gene, Accession, CAS # | NCBI: NP_004788.1, UniProt: Q15848 |
| Catalog # | ADI0501 |
| Price | $105, $320, $960 |
| Order / More Info | Recombinant human Adiponectin/Acrp30 protein from NKMAX Co. Ltd. |
| Product Specific References | Jung TW, et al. Adiponectin protects human neuroblastoma SH-SY5Y cells against acetaldehyde-induced cytotoxicity. (Biochem Pharmacol. 2006){https://pubmed.ncbi.nlm.nih.gov/16814256/};;Jung TW, et al. Adiponectin protects human neuroblastoma SH-SY5Y cells against MPP+-induced cytotoxicity. (Biochem Biophys Res Commun. 2006){https://pubmed.ncbi.nlm.nih.gov/16554029/} |
NKMAX Co. Ltd.
NKMAX Co. Ltd.
6F, SNUH Health Care Innovation Park
172 Dolma-ro, Bundang-gu
Seongnam-si, Gyeonggi-do 13605 REPUBLIC OF KOREA
P: +82-31-8017-8114
F: +82-31-8017-8124
salesbio@nkmax.com
http://www.nkmaxbio.com
Profile of NKMAX Co. Ltd.
Return to Products